Bank Of New York Mellon Corp Dexcom Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$104.0 - $122.92 $520 Million - $615 Million	5,000,126 New	5,000,126 $581 Billion
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $452 Million - $652 Million	5,315,873 New	5,315,873 $602 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $18 Million - $22.2 Million	236,233 Added 4.47%	5,526,643 $445 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $275 Million - $537 Million	4,039,303 Added 322.86%	5,290,410 $394 Million
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $6.4 Million - $8.86 Million	68,069 Added 5.75%	1,251,107 $640 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $4.41 Million - $5.53 Million	-33,966 Reduced 2.79%	1,183,038 $635 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $1.51 Million - $2.02 Million	-14,134 Reduced 1.15%	1,217,004 $666 Million
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $3.32 Million - $4.43 Million	-41,008 Reduced 3.22%	1,231,138 $131 Million
Q1 2021 May 13, 2021	BUY	$84.79 - $104.74 $2.86 Million - $3.53 Million	33,739 Added 2.72%	1,272,146 $114 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $2.95 Million - $3.96 Million	37,862 Added 3.15%	1,238,407 $114 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $10.4 Million - $12.3 Million	-108,830 Reduced 8.31%	1,200,545 $124 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $16.3 Million - $27.5 Million	260,708 Added 24.86%	1,309,375 $133 Million
Q1 2020 May 06, 2020	SELL	$47.79 - $75.63 $1.9 Million - $3.01 Million	-39,750 Reduced 3.65%	1,048,667 $70.6 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $1.75 Million - $2.73 Million	-47,714 Reduced 4.2%	1,088,417 $59.5 Million
Q3 2019 Nov 07, 2019	SELL	$35.53 - $43.8 $141,587 - $174,543	-3,985 Reduced 0.35%	1,136,131 $42.4 Million
Q2 2019 Aug 12, 2019	BUY	$27.84 - $38.92 $6.58 Million - $9.19 Million	236,189 Added 26.13%	1,140,116 $171 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $3.14 Million - $4.28 Million	-111,987 Reduced 11.02%	903,927 $108 Million
Q4 2018 Feb 11, 2019	BUY	$26.99 - $37.37 $3.16 Million - $4.38 Million	117,195 Added 13.04%	1,015,914 $122 Million
Q3 2018 Nov 09, 2018	BUY	$23.35 - $36.72 $3.04 Million - $4.78 Million	130,048 Added 16.92%	898,719 $0
Q2 2018 Aug 06, 2018	SELL	$17.54 - $25.22 $1.19 Million - $1.71 Million	-67,859 Reduced 8.11%	768,671 $73 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $1.32 Million - $1.88 Million	-101,300 Reduced 10.8%	836,530 $62 Million
Q4 2017 Feb 09, 2018	BUY	$11.12 - $15.38 $10.4 Million - $14.4 Million	937,830	937,830 $53.8 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account